IL1B and myeloid sarcoma: Our previous finding showed that IL-1β was able to increase glutamatergic synaptic transmission and to inhibit GABAergic inhibitory postsynaptic currents in MS chimeric ex-vivo models (Rossi et al., 2012a,b).